TVTX - Travere Therapeutics Inc.

Healthcare - Sector
Coverage

TVTX is currently covered by 9 analysts with average potential upside of $14.16 (58.96%) backed by 1 price targets and 39 ratings. Analyst's average stock valuation to be materialised ratio is 13.33% with an average time for price targets to be met of 38.33 days.

Most recent stock forecast was given by DO KIM from PIPER SANDLER on 11-Jan-2023.

Highest price target for TVTX is 31, Lowest price target is 15, average price target is 23.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

42

$20.12 (91.96%)

38

18 days ago

0/10 (0%)

$16.75 (74.99%)

Buy

38

$16.12 (73.67%)

45

3 months 9 days ago

1/5 (20%)

$14.79 (67.16%)

156

Buy

36

$14.12 (64.53%)

42

3 months 12 days ago

0/4 (0%)

$16.45 (64.30%)

Buy

42

$20.12 (91.96%)

42

6 months 15 days ago

0/2 (0%)

$18.75 (80.83%)

Buy

40

$18.12 (82.82%)

36

1 years 1 months 12 days ago

0/5 (0%)

$10.95 (49.17%)

Show more analysts